Board of Directors
Jill Durovsik (Chair)
Jill Durovsik (Chair)
Jill Durovsik was a founding board member of the Wellness Community of Philadelphia (now Cancer Support Community Philadelphia) over 25 years ago and has served on its board in addition to serving as Chairwoman of the organization. Today, Jill serves on the board of the Cancer Support Community Headquarters and is Chairwoman of the organization’s newly established Research and Training Institute. Ms. Durovsik’s support and vision has been deeply inspired by family circumstance and has fueled her dedication to helping patients and families triumph over the threat of cancer in their daily lives.
After graduating Skidmore College, Ms. Durovsik entered the business world and spent the bulk of her career in financial services and building entrepreneurial companies. At Merrill Lynch she was responsible for developing marketing and financial products for worldwide distribution. Later, Ms. Durovsik founded Corporate Concierge Inc. and built it into a highly successful consumer services company.
Ms. Durovsik is a strong advocate of the arts and an involved community leader. She has been an Associates Board Member at the Philadelphia Museum of Art and a founder of the museum’s largest family program, dedicated to introducing children and families to our nation’s cultural endowment. Ms. Durovsik attended the Barnes Foundation art study program and is a member of the National Advisory Council of the Tang Teaching Museum at Skidmore College. Ms. Durovsik is currently pursuing a Master’s Degree in nonprofit leadership at University of Pennsylvania’s School of Social Policy and Practice.
Ms. Durovsik and her husband Tom, an entrepreneur and currently Chief Executive Officer of FreedomPay, Inc., have three children; Taylor, Paige and John; and reside in Villanova, Pennsylvania.
Vertex Pharmaceuticals Inc., Executive Vice President & Chief Commercial Officer
Stuart A. Arbuckle joined Vertex in September 2012. As Vertex’s Executive Vice President and Chief Commercial Officer, Mr. Arbuckle oversees Vertex’s global commercial team, which is responsible for the company’s sales, marketing, patient support, market research and other activities that support the approved use of Vertex’s two medicines.
Mr. Arbuckle has more than 25 years of experience in leading global sales and marketing efforts at biopharmaceutical companies. Prior to joining Vertex, Mr. Arbuckle held multiple commercial leadership roles at Amgen, Inc., a 17,000-person biotechnology company. As Vice President and General Manager, Oncology Business Unit, he led sales, marketing, patient advocacy and access efforts for Amgen’s portfolio of cancer medicines. He was responsible for sales and marketing efforts for Aranesp®, Neulasta® and NEUPOGEN®, which accounted for more than $5 billion in sales in 2011, and led the successful launches of XGEVA® and Nplate®. Most recently, he served as Vice President and Regional General Manager where he led efforts to expand Amgen's presence in Japan and emerging markets in Asia, the Middle East and Africa.
Prior to these roles, Mr. Arbuckle spent more than 15 years at GlaxoSmithKline (GSK) plc, where he held sales and marketing roles of increasing responsibility for medicines aimed at treating respiratory, metabolic, musculoskeletal, cardiovascular and other diseases. He joined GSK after earning a degree in pharmacology and physiology from the University of Leeds in the United Kingdom. Mr. Arbuckle currently serves as a national board member of the Cancer Support Community, an international non-profit dedicated to providing support, education and hope to people affected by cancer, and on the Health Section Governing Board for the Biotechnology Industry Organization.
William J. Ashbaugh
William J. Ashbaugh
William J. Ashbaugh began his corporate career with the Union Carbide Corporation in 1961. He worked in the accounting department at a manufacturing plant in Bennington, VT. In 1967, he joined the Procter & Gamble Company’s finance organization where he held a variety of financial positions, including Comptroller of the Food Division, before retiring in 1998.
Mr. Ashbaugh earned a BS in economics from Baldwin-Wallace College in 1961 and an MS in economics from Rensselaer Polytechnic Institute in Troy, NY in 1966. He completed his graduate work at night school while working for Union Carbide.
Since joining the board of The Wellness Community in Cincinnati (now Cancer Support Community Cincinnati), Mr. Ashbaugh has been active in a variety of areas. He joined the board in 1993 and was appointed Treasurer and Finance Committee chair soon after. In 1998, he was appointed interim CEO of The Wellness Community National, predecessor of the Cancer Support Community, which was originally headquartered in Cincinnati after organizing in Los Angeles. Mr. Ashbaugh was appointed chair of the National Board when Kim Thiboldeaux was hired as CEO. Later Bill was appointed chair of the Finance Committee, and he is currently a committee member and chair of the Audit Committee; he served as Treasurer from 2004 to 2009.
Mr. Ashbaugh lives in Cincinnati. His wife Nancy indulges herself in used books. They have three children and five grandchildren.
David C. Ashworth
David C. Ashworth
DCAshworth Consulting, Principal
David C. Ashworth currently is the Principal at the DCAshworth Consulting and is Strategic Advisor to HealthGroup West. He has extensive healthcare planning, operations and real estate development experience, including 27 years with Presbyterian Healthcare System.
Mr. Ashworth’s business development experience includes mergers, acquisitions, divestitures, start-ups and partnership development between not-for-profit and for-profit health systems, physicians and related third parties, as well as the strategic use of real estate assets.
He is the recipient of the Senior Level Healthcare Executive Regent’s Award from the American College of Healthcare.
AEG Global Partnerships, Vice President
Nick Baker is a Senior Vice President in the Global Partnerships division of AEG. The Global Partnerships business group, formed atop the company’s organizational structure, guides AEG’s continued development in the area of sponsorship and naming rights sales, partnership activation, international business development, and premium sales existing within AEG Facilities, live events, sports franchises, and music properties. The division is responsible for over $500 million of gross sponsorship revenue and premium sales with an expected growth rate in the next several years.
Since joining AEG in 2005, Mr. Baker has quickly risen within the group from activation, managing such large partners as The Home Depot, AT&T and DirecTV, to the sales and business development side, becoming the youngest Vice President within the division. Responsible for the relationship with Amgen, title partner of AEG’s Amgen Tour of California cycling event, Mr. Baker has successfully negotiated and extended the multi-year entitlement agreement on two separate occasions.
Mr. Baker played point in securing the naming rights of two core AEG Facilities venues, the Valley View Casino Center (San Diego, California), BBVA Compass Stadium (Houston, Texas), as well as being a member of the executive team that finalized a global relationship with StubHub, which includes Naming Rights of StubHub Center (Carson, California) and exclusivity within AEG’s ticketing company, AXS.com. In April 2013, Mr. Baker directed AEG efforts in finalizing the naming rights agreement with Allianz for a venue in Sao Paulo, Brazil.
As of 2014, Mr. Baker currently oversees all revenue budgets and sales team management of AEG Sports Event & AEG Facilities in North & South America. In addition, he has played key roles in developing, negotiating and activating large scale global relationships for AEG Facilities, Sports Teams and Music Assets with companies such as ABM, MillerCoors, City National Bank, Corona, Samsung, Toshiba, Tyco, UnitedHealthCare, Waste Management and many more.
Lauren G. Barnes
Lauren G. Barnes
Vertex Pharmaceuticals, Vice President, Managed Markets
Lauren Barnes is Vice President, Managed Markets at Vertex Pharmaceuticals, a global biotechnology company that aims to discover, develop and commercialize innovative medicines so people with serious diseases can lead better lives. In addition to its clinical development programs focused on cystic fibrosis, Vertex has more than a dozen ongoing research programs aimed at other serious and life-threatening diseases.
Ms. Barnes was previously Senior Vice President, Avalere Health. At Avalere, she provided strategic payer planning and public policy expertise to clients in the pharmaceutical and biotechnology industries to assist in the successful commercialization of their products. Prior to joining Avalere, Ms. Barnes was Director of the Payment and Coverage Group at Amgen. Immediately prior to her time with Amgen, she worked for the Centers for Medicare & Medicaid Services in the Coverage and Analysis Group and sat on the Healthcare Common Procedure Coding System panel.
Ms. Barnes has a BA in Public Health and a MHS in Health Care Policy from Johns Hopkins University. She serves on the board of the Cancer Support Community, an international nonprofit dedicated to providing support, education, and hope to people affected by cancer.
Harry B. Davidow
Harry B. Davidow
A native of Roanoke, Virginia, Harry Davidow established a thriving real estate and property management business in and around Cincinnati, Ohio. As active philanthropists, Mr. Davidow and his wife April have supported and raised funds for several nonprofit organizations in Ohio. Chief among them is the Cancer Support Community. In 1990, Mr. and Mrs. Davidow, along his sister Lynn Stern, raised $250,000 to launch a Wellness Community chapter in Cincinnati (now Cancer Support Community). He became the founding Board Chair and went on to join the board of the headquarters organization, where he was ultimately elected as the Chairman. In addition to Cancer Support Community, Mr. Davidow has served on the boards of numerous community and civic organizations, including the Cincinnati Apartment Association, the Jewish Community Center, the Cincinnati Opera Association, Cedar Village Nursing Home, the American Jewish Committee and the Jewish Federation of Cincinnati.
Mr. Davidow received a Bachelor of Business Administration degree from the University of Cincinnati in 1955.
Senseonics, Inc., Chief Financial Officer
Mr. Elsey has served in executive finance positions for both privately and publicly held companies. He is currently Chief Financial Officer of Senseonics, Incorporated. Senseonics is developing the first fully implantable continuous glucose sensor designed for highly accurate, long-term wear. Previously, he served as the CFO of Regado Biosciences, a public biopharmaceutical company. He was the CFO of LifeCell, Inc., a private regenerative medicine company, from 2013-2014 and a Senior VP and CFO at Emergent BioSolutions, Inc., a public biopharmaceutical company, from 2005-2012.
Mr. Elsey also served as the Director of Finance and Administration at IGEN International, Inc., a public biotechnology company, and its successor BioVeris Corporation, from 2000 to 2005. He also served as Director of Finance at Applera and in several finance positions at IBM, Inc.
Mr. Elsey serves on the board of directors of RegeneRx Biopharmaceuticals, a public biopharmaceuticals company, as well as on the board of the Cancer Support Community. He received an MBA in finance and a BA in economics from Michigan State University.
Cancer Support Community – Greater Philadelphia, CEO
Kelly Harris, MSS, LCSW, ACSW received her Master’s degree in clinical social work from the Bryn Mawr College Graduate School of Social Work and Research in Bryn Mawr, PA and her Bachelor of Arts degree in psychology from Cedar Crest College in Allentown, PA.
Ms. Harris also has a post graduate certificate from LaSalle University in nonprofit management. Currently, she is taking post graduate courses at Harvard University. She is a licensed clinical social worker and has over 30 years of experience in the fields of child welfare, international and domestic adoption, foster and oncology social work. She has served and continues to serve on the boards of several nonprofit organizations and provides trainings in the areas of strategic planning, program development, staff and volunteer development and diversity.
Avalere, Vice President, Reimbursement and Product Commercialization
Fauzea Hussain is a Vice President with Avalere Health. Ms. Hussain works with a range of clients including life science companies, physician and provider specialty societies as well as patient advocacy groups. She advises life sciences clients on integrated market access strategies, product commercialization tactical plans, and public and private payer engagement activities. Ms. Hussain collaborates with life sciences companies on integrated market access strategies aimed at optimizing product positioning by ensuring that evidence generation activities align with the evolving demands of payers, providers and patients as well as coding bodies such as the AMA CPT Editorial Panel. Ms. Hussain has extensive experience monitoring and assessing the impact of the evolving reimbursement, cost and value landscape for oncology products. She advises clients on the evolving impact of alternative payment models, clinical guidelines, pathways and quality measures on care delivery and patient access.
Ms. Hussain advises physician and provider specialty society clients on a range of policy issues affecting physician payment and clinical practice. She has worked with clients to evaluate the opportunities to support enhanced payment for primary care and specialty care providers, including medical and surgical oncologists. She has advised clients on coding strategies for specific services as well as larger coding initiatives focused on care transitions, specialty specific care coordination and novel patient management services. She has a deep understanding of the issues affecting coverage and payment for physician and non-physician services. She has collaborated with a number of non-physician provider groups on legislative and policy initiatives to support Medicare recognition and payment.
Ms. Hussain advises patient advocacy organizations on their state and federal policy platforms. Areas of focus often include: enhancing reimbursement for preferred patient treatments, novel technologies, improving awareness of optimal settings of care or centers of excellence, optimizing clinical trial design and enrollment, creation of learning networks to support patient education and access and patient transparency considerations in alternative payment models.
For more than eight years, Ms. Hussain has served as a key member of Avalere’s reimbursement team. She works collaboratively with Avalere experts to execute the activities outlined above.
Prior to joining Avalere, Ms. Hussain worked as the assistant director of reimbursement for the American Academy of Physician Assistants (AAPA). Fauzea joined the AAPA shortly after passage of the Balanced Budget Act of 1998 which granted PAs Medicare recognition. For the next seven years, she supported state and federal efforts to support recognition of PA services across public and private payers. In this role she honed her expertise on physician coding and payment and the intricacies of non-physician payment.
Ms. Hussain has also worked as a medical assistant and researcher for a clinical advisory services firm. She has a BA in psychology, a BS in biology, and a MPH from George Washington University.
ABM, Senior Vice President, Onsite Sales
Charlotte Jensen-Murphy is Senior Vice President, ABM. She has 23 years of experience in executive service operations and sales management and is responsible for the overall growth and retention of ABM’s business in both the sports and entertainment as well as in certain segments of the commercial real estate markets. Understanding the unique needs and expectations of the clients in this areas, she plays a key role in managing strategic relationships locally, nationally and internationally.
Prior to being promoted to her current role, Ms. Jensen-Murphy was responsible for creating tactical partnerships with global customers which prompted ABM’s growth into Europe. Charlotte’s past responsibilities include VP Strategic Sales, VP Operations, and Financial Controller, as well as roles in HR, tax administration and account management.
Ms. Jensen-Murphy’s background, combined with her commitment to creating an enhanced customer experience, has given her a unique perspective for advising clients on their facility service programs. She and her team have been recipients of multiple awards for providing superior service to long-term clients, and they continue to focus on building trust in ABM’s service delivery through deep relationships.
Ms. Jensen-Murphy received a Bachelor of Science in business administration from Susquehanna University in Pennsylvania with a minor in Spanish. She currently serves as a Trustee for the San Diego County Employers Trust Fund, and is actively involved with the Sports Business Journal, Stadium Managers Association, Green Sports Alliance, The International Association of Venue Managers and BOMA.
Paula J. Malone, PhD
Paula J. Malone, PhD
Paula J. Malone, PhD, is Founder and President of Wings Foundation, Inc. She is a retired developmental/clinical psychologist, who first worked in hospital and clinic settings developing and running programs for families and children, neonates to adolescents. In private clinical practice, she developed a multi-disciplinary practice, Comprehensive Psychological Services, LLC, to serve the mental health of children, families and adults throughout Delaware and portions of Pennsylvania and New Jersey. She became involved with The Wellness Community Delaware (now Cancer Support Community Delaware), volunteering and ultimately becoming a Board Member. In 2004, Dr. Malone joined the National Board of The Wellness Community (now Cancer Support Community). In 2010, Dr. Malone and the Wings Foundation made a leadership gift to Cancer Support Community’s Research and Training Institute (RTI). Dr. Malone’s interest in supporting CSC, its affiliates and the RTI, stems not only from her previous professional involvement with cancer patients, but from personal issues as well: she has survived longer, cancer-free, than any other female for generations on both sides of her family and has been a caregiver to two who passed away. She has three children and three grandchildren. Dr. Malone is a licensed pilot and a certified scuba diver.
Michael M. Paese
Michael M. Paese
Goldman Sachs, Global Co-head, Office of Government Affairs
Michael Paese is global co-head of the Office of Government Affairs at Goldman Sachs. He joined the firm as a managing director in 2009. Prior to joining Goldman Sachs, Mr. Paese was executive vice president for Global Advocacy at the Securities Industry and Financial Markets Association (SIFMA), where he was responsible for global legal, governmental and legislative affairs and advocacy initiatives. Previously, he was Deputy Staff Director of the US House Financial Services Committee and he also had joint responsibility for Committee policy related to the banking, securities and insurance industries.
Earlier in his career, Mr. Paese worked at Mercantile Bankshares Corporation, where he held several senior positions, including executive vice president and chief administrative officer. Before joining Mercantile, he held the position of Senior Minority Counsel with the House Financial Services Committee. Mr. Paese has also held positions at JPMorgan Chase & Co. and was an associate at Davis Polk & Wardwell with the financial institutions practice.
Mr. Paese earned a BA from Notre Dame and a JD from Notre Dame Law School.
Bristol-Myers Squibb, Senior VP, U.S. Access and Government Affairs
Ray Sacchetti began his career at Bristol-Myers Squibb (BMS) in 1987 and has held US and Global leadership positions in marketing, sales, and market access. He is an industry leader on key issues affecting access to innovative medicines and represents BMS on the board of BIO and is vice chairman of HINJ. His current responsibilities include: reimbursement services, pricing, contracting, state government affairs, distribution and access strategy across all BMS’s US businesses. In addition, he provides commercial leadership to BMS Puerto Rico.
Mr. Sacchetti has led the transformation of the US access team and continues to drive customer centered innovation as BMS becomes the industry-leading diversified biopharmaceutical company. His 200 person US access team serves as a catalyst for change as the BMS specialty pharmaceutical portfolio brings new innovation to the market.
In addition to his twelve years in US market access leadership, Mr. Sacchetti has led product marketing for Plavix, Avapro, Avalide, Tequin, Cefzil and Glucophage XR and since 2004 has lead several key business units for BMS. He created the BMS Hepatitis business and launched Baraclude for the treatment of Hepatitis B. He then spent several years leading BMS’s US and Global partnership with Sanofi Aventis for Plavix. In 2009 Ray was appointed Senior Vice President, US Virology and in 2011 took on his current leadership role as Senior Vice President, U.S. Access and Government Affairs.
Andrew Sandler (Interim Vice-Chair)
Andrew Sandler (Interim Vice-Chair)
BuckleySandler, LLP, Chairman and Executive Partner
Andrew L. Sandler, Chairman and Executive Partner of BuckleySandler LLP and Chief Executive Officer of Treliant Risk Advisors LLP, is widely recognized as a trusted strategic legal advisor to the financial services industry.
Drawing on his deep experience and expertise in representing many of the nation’s leading banks and financial services companies for over two decades, Mr. Sandler provides strategic advice to boards, C-Suite executives, and in-house legal and compliance professionals as they seek effective holistic business solutions to the regulatory and enforcement challenges of today’s complex and often difficult regulatory environment. His current practice focuses on representing clients in regulatory examinations and enforcement actions by federal and state banking and enforcement agencies, including all federal banking agencies, the DOJ and the CFPB in matters involving consumer protection, fair lending, FIRREA, the False Claims Act and AML/BSA. He represents officers and directors with respect to regulatory proceedings and litigation involving failed financial institutions. He has served as lead defense counsel in nearly 100 class action lawsuits and has represented financial institutions and other entities and persons in a broad array of complex litigation matters for more than 20 years.
As Chief Executive Officer of Treliant Risk Advisors, Mr. Sandler leads a multi-disciplinary firm that provides consulting, compliance and transaction advisory assistance to the financial services industry.
Chambers USA has consistently recognized Mr. Sandler as one of America’s leading lawyers in the financial services industry. He currently holds Chambers USA’s top rating in the areas of Financial Services Regulation: Banking Enforcement & Investigations and Compliance, as well as in Financial Services Regulation: Consumer Finance Compliance and is recognized as a “Star Individual” in Financial Services Regulation: Consumer Finance Litigation. Mr. Sandler has been named to BTI's Client Service All Stars list. He is consistently recognized in Best Lawyers, including recognition as "Lawyer of the Year" in the field of Litigation - Banking and Finance (Washington, D.C.). He has been named one of 30 D.C. "Superstar" lawyers by Washingtonian Magazine and a "Star of the Bar" in Banking and Financial Services. Legal Times named him a “Legal Visionary” for his role in founding BuckleySandler and, more recently, a “Deal Maker of the Year” for his work in navigating complex transactions through the regulatory process. Mr. Sandler is also a Fellow in the American College of Consumer Financial Services Lawyers (ACCFSL).
Mr. Sandler is an active participant in community and professional organizations. He serves on the Board of Advisors for the American Association of Bank Directors and has had many leadership roles in the Litigation and Business Law Sections of the American Bar Association, including Chair of the Consumer and Civil Rights Committee and Vice Chair of the Banking Law Committee. He serves on the National Board of Directors of the Cancer Support Community, University of Pennsylvania Law School Alumni Society Board of Managers, The George Washington University Center for Law, Economics & Finance Advisory Board, and the Board of the Kolar Charitable Foundation of BuckleySandler LLP.
Mr. Sandler received his JD from the University of Pennsylvania Law School, his MBA from the University of Pennsylvania, Wharton School, his M.A. from the University of Warwick (U.K.) (Rotary Foundation Fellow), and his BA from Union College.
Ken Scalet spent 17-years at Accenture, working largely in the health care industry on large-scale, technology enabled programs. As a partner, Mr. Scalet launched Accenture’s Federal Health practice. Following his retirement from Accenture in 2004, Mr. Scalet established in an independent health IT consultancy. He has also channeled his professional energy toward board service for local and national not-for-profit organizations. He has served on the Board of Directors of Cancer Support Community since 2003 and serves as the chair of the Technology Committee. Mr. Scalet received a BA in economics from Franklin & Marshall College in 1987. He is married with 3 children and lives in Rockville, Maryland.
Charles R. Scheper
Charles R. Scheper
Bexion, Chairman of the Board
Chuck Scheper is the Chairman of the Board of Bexion Pharmaceuticals LLC, an emerging bio-tech company focused on the development and commercialization of innovative cures for cancer. He served as interim Mayor of Covington, Kentucky in 2012, and until his retirement in 2010, he served as the Chief Operating Officer at Great American Financial Resources, a $20 billion life and annuity company based in Cincinnati, Ohio.
Mr. Scheper has been involved with numerous volunteer efforts in the community over the years and currently he is the Chair of the Catalytic Development Funding Corp of Northern Kentucky, and he serves on the boards of Vision 2015, the Metropolitan Club and the Greater Cincinnati Foundation. He is also a member of the World President's Organization.
Mr. Scheper is a cancer survivor and his journey to wellness led him to become active in various causes related to cancer, including the Cancer Support Community, where he has served as the National Board Chairperson and currently is a board member. He is a graduate of Thomas More College, and he and his wife, Julie Geisen Scheper, live in the historic Licking Riverside neighborhood of Covington, KY.
Cancer Support Community of Greater St. Louis, Program Director
Renata Sledge, MSW, LCSW is Program Director at Cancer Support Community of Greater St. Louis. Ms. Sledge has focused on collaborating with people and families impacted by chronic illness in improving quality of life, promoting positive family adjustment and encouraging self-management of chronic illness. She has published and presented on areas ranging from music therapy in cancer care, depression management with end stage renal disease, ethics and technology in social work practice. Ms. Sledge graduated from Indiana University with her Masters of Social Work degree and from St. Mary of the Woods College with her BS in music therapy.
Brinks Corporation, Vice President and Chief Human Resources Officer
Holly Tyson is Vice President and Chief Human Resources Officer of The Brink's Company (NYSE: BCO), a global leader in security-related services, including armored car transportation, money processing, long-distance transport of valuables, vaulting and other value-added solutions. Brink’s employs about 65,000 people and has presence in over 100 countries. As CHRO, Ms. Tyson is responsible for leading the overall talent strategy for the organization worldwide and ensuring the organizational culture, structure and approaches are aligned to enable the company’s success. She has been with Brink’s since August, 2012.
Prior to Brink’s, Ms. Tyson led the HR function for the $13B US Commercial business for Bristol-Myers Squibb, Co, including planning and management of current and future talent needs, organization design and development, performance management, and career and capability development.
She began her career with Accenture (then Andersen Consulting) in their Change Management practice and then went on to hold varying leadership positions across industries and functions, including roles at CIGNA Corporation and leading an OD practice at Alliance Consulting.
Ms. Tyson holds a Master’s Degree in organizational psychology from Columbia University and holds Bachelor’s Degrees in English and psychology from the College of William and Mary. She serves on the Board of Directors for the Cancer Support Community and on the Executive Advisory Council for the University of Richmond Robins School of Business. She lives in Richmond, Virginia with her husband and two sons.
Cancer Support Community, Chief Executive Office
Kim Thiboldeaux joined The Wellness Community in 2000 as President and Chief Executive Officer. In 2009, the headquarter offices of The Wellness Community and Gilda’s Club joined forces to become the Cancer Support Community, one of the largest providers of social and emotional support worldwide, where Kim has maintained her role as President and CEO. The combined organization is also likely the largest employer of psychosocial oncology mental health professionals, advancing the idea that psychosocial care is as important as medical care in the face of a cancer diagnosis. The Cancer Support Community provides social and emotional support through a network of nearly 50 local affiliates, more than 100 satellite locations and online at www.cancersupportcommunity.org. The organization also maintains a Research & Training Institute in Philadelphia, PA.
Formerly the Director of Patient Relations for Oncology & Transplant at Hoffmann-LaRoche, Inc., Kim brings to this position a wealth of experience in health care, patient education and national patient advocacy. Kim serves in numerous leadership roles in the cancer and health care communities including: founding board member of ENACCT (Education Network to Advance Cancer Clinical Trials), member of the American College of Surgeons Commission on Cancer, Co-Chair of the Alliance for Quality Psychosocial Care, and Advocacy Board Member of the Ruesch Center for the Cure of GI Cancers at Lombardi Comprehensive Cancer Center. Prior to joining Roche, she served as the Director of Corporate Relations at Whitman-Walker Clinic, a Washington, D.C.-based clinic that provides comprehensive services to people with HIV and AIDS.
Kim co-authored The Total Cancer Wellness Guide, which was published by BenBella Books on June 1, 2007. This timely book is a roadmap for all people affected by cancer and offers helpful tips on treatment decisions, side effect management, social and emotional issues and more. She is also the host of Frankly Speaking About Cancer with the Cancer Support Community, an award-winning Internet talk radio show that airs weekly on VoiceAmerica.com and is aimed at informing and inspiring listeners to live well with cancer.
Eli Lilly & Company, Senior Director of Global Advocacy and Professional Relations
Tom Wallace is the Senior Director of Global Advocacy and Professional Relations at Eli Lilly and Company. In addition, he is a member of the Global Corporate Affairs Leadership Team, which has responsibility for the Company’s public affairs function worldwide, led by the Senior V.P. of Corporate Affairs.
Mr. Wallace has led the company’s outreach to patient advocacy groups and health professional associations since 2002, expanding from leading the U.S. function to leading a global function in 2008. His role includes defining and managing how the company interacts with external organizations. The focus areas are gaining insight about what will improve innovation and meet patient’s needs, and building direct and virtual alliances through digital engagement to improve health care delivery and regulatory systems and public policies. Mr. Wallace has worked with Lilly executives to develop and implement several initiatives to improve transparency within the healthcare field, and to establish principles for interactions with external organizations. In several cases Lilly is credited with setting the trend for Industry transformation.
Employed by Lilly since 1989, Mr. Wallace’s roles have included those in state government relations, new product planning and sales. Prior to joining Lilly, he served as the Assistant Director of the State of Indiana Washington, D.C. Office under Governor Robert D. Orr. He was selected for the Governor’s Fellowship program, a state program modeled after the White House Fellows program. Mr. Wallace is a graduate of Butler University and holds a Masters of Public Affairs degree from Indiana University.
Mr. Wallace serves on several advisory boards and was chairman of the PhRMA Alliance Section from 2006 to 2008, during a time of great change to the U.S. Medicare Part D prescription drug benefit. He has been an active participant about broader health care reforms. He is on the national boards of the National Health Council and Cancer Support Community. Other engagements have included speaking roles at the “Coach K Leadership Institute” at Duke University and participating in the Wharton-Lilly Leadership Program for nonprofit health care executives at the University of Pennsylvania.
Mr. Wallace lives in the Washington, D.C. area; he and his wife Lynn have two college age sons.
Ogilvy CommonHealth Specialty Marketing, President
Michael Zilligen is a seasoned marketing leader in the pharmaceutical and device marketplace, with 25 years of health care marketing, medical education, managed markets strategy and professional promotion expertise. He is responsible for all operations at Specialty Marketing focused on oncology, virology, medical device and rare diseases. Prior to assuming leadership at Ogilvy CommonHealth Specialty Marketing, he was President of ProCom where he repositioned the group from CME to promotional medical education.
Previously, Mr. Zilligen was a SVP with Ogilvy Payer Marketing providing managed markets strategic guidance to health care clients. He was responsible for reimbursement strategy, developing managed care marketing solutions across customer segments that assist clients in improving or protecting formulary access and pulling through reimbursement advantages to drive incremental sales.
Prior to joining OCH Payer Marketing, Mr. Zilligen was Group Director of Marketing for the Interventional Cardiology and Radiology portfolio of products at B. Braun Medical, a leader in medical devices. This included responsibility for global brand and franchise strategic planning, professional promotion, new product development and educational programming. Before his tenure in the device industry, Mr. Zilligen spent five years with Marion Merrell Dow in institutional sales & managed care account management. His expertise includes domestic and international product management, new product introductions, hospital strategy, and specialty markets. He has a unique skill set consisting of professional promotion, medical education, product marketing and managed care – acquired during positions of increasing responsibility.